Area of focus

Health Care Services

Thriving in the ever-changing health care industry requires creative problem solving and solutions that meet the demands of tomorrow’s environment. That’s what you’ll get with us.

We do more than just counsel companies in the health sector on legal and regulatory issues — we’re strategic...

Representative experience

Ranked Band 1 for Healthcare and Life Sciences in France and Italy by The Legal 500 EMEA 2015.

Ranked Band 2 for Life Sciences and Healthcare by Chambers USA 2015 and The Legal 500 USA 2015.

Seven members of our health team have significant experience at the U.S. Department of Health and Human Services (HHS).

Ten of Hogan Lovells’ lawyers previously practiced in the FDA’s Office of the Chief Counsel. Collectively they have spent 100 years inside the agency.

Hogan Lovells Publications

CMS Radiation Oncology Model proposed rule – summary and early insights Health Alert

Last week, the Centers for Medicare & Medicaid Services (CMS) announced new details of a proposed bundled payment model for radiation oncology services (RO Model), which would make...

Quick view Full view

Blog Post

FDA launches temporary “TRIP” program to help HCT/P sponsors gain regulatory clarity

Acting Food and Drug Administration (FDA) Commissioner Ned Sharpless, M.D. recently announced that FDA is implementing a temporary program called the Tissue Reference Group Rapid...

Quick view Full view

Hogan Lovells Publications

U.S. Supreme Court ruling expands scope of Medicare notice-and-comment requirement Health Alert

On 3 June 2019 the U.S. Supreme Court held in Azar v. Allina Health Services that Medicare interpretive guidance must go through notice-and-comment if it establishes or changes a...

Quick view Full view

Hogan Lovells Publications

CMS proposes long-awaited draft guidance on co-located hospitals Health Alert

On May 3, 2019, the Centers for Medicare & Medicaid Services (CMS) issued draft manual guidance for surveyors evaluating whether hospitals that are co-located with other hospitals (or...

Quick view Full view

Hogan Lovells Publications

Life sciences and health care horizons 2019

Quick view Full view

Webinar

Proposed AKS rewrite on drug rebates: The impact and challenges ahead

The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...

Quick view Full view
Loading data